Jeffrey Farrow - Mar 18, 2025 Form 4 Insider Report for Tarsus Pharmaceuticals, Inc. (TARS)

Role
Chief Financial Officer and Chief Strategy Officer
Signature
/s/ Jeffrey Farrow, Attorney-in-Fact
Stock symbol
TARS
Transactions as of
Mar 18, 2025
Transactions value $
-$178,306
Form type
4
Date filed
3/20/2025, 09:48 PM
Previous filing
Mar 18, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARS Common Stock Sale -$59.4K -1.28K -4.91% $46.29 24.9K Mar 18, 2025 Direct F1
transaction TARS Common Stock Sale -$59.4K -1.25K -5.04% $47.40 23.6K Mar 19, 2025 Direct F1
transaction TARS Common Stock Sale -$59.4K -1.19K -5.02% $50.11 22.4K Mar 20, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

Remarks:

Chief Financial Officer and Chief Strategy Officer